Total Payments
$2,812
2024 Payments
$535.56
Companies
7
Transactions
72
Payment Breakdown by Category
Food & Beverage$2,728 (97.0%)
Consulting$50.00 (1.8%)
Education$33.80 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,728 | 67 | 97.0% |
| Consulting Fee | $50.00 | 1 | 1.8% |
| Education | $33.80 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $835.41 | 25 | $0 (2023) |
| Medtronic USA, Inc. | $658.89 | 13 | $0 (2019) |
| REVANCE THERAPEUTICS, INC. | $427.70 | 8 | $0 (2024) |
| ABBVIE INC. | $427.34 | 16 | $0 (2024) |
| Merz North America, Inc. | $364.63 | 6 | $0 (2023) |
| Intersect ENT, Inc. | $50.00 | 1 | $0 (2017) |
| Allergan, Inc. | $47.54 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $535.56 | 13 | REVANCE THERAPEUTICS, INC. ($427.70) |
| 2023 | $594.00 | 13 | AbbVie Inc. ($319.48) |
| 2022 | $133.17 | 6 | Galderma Laboratories, L.P. ($84.98) |
| 2021 | $806.43 | 24 | Galderma Laboratories, L.P. ($617.10) |
| 2020 | $33.46 | 2 | Allergan, Inc. ($33.46) |
| 2019 | $55.83 | 1 | Medtronic USA, Inc. ($55.83) |
| 2018 | $447.26 | 8 | Medtronic USA, Inc. ($447.26) |
| 2017 | $205.80 | 5 | Medtronic USA, Inc. ($155.80) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 11/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $48.92 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 08/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $50.78 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.43 | General |
| 07/10/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $52.87 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $51.61 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/18/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/28/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $37.92 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 04/24/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $47.44 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 02/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 12/18/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $22.04 | General |
| 09/20/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $20.48 | General |
| 06/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $34.18 | General |
| 05/19/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $141.19 | General |
| Category: Musculoskeletal | ||||||
| 04/29/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $133.33 | General |
| 04/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $149.98 | General |
| 04/28/2023 | AbbVie Inc. | — | Education | In-kind items and services | $8.45 | General |
| 04/28/2023 | AbbVie Inc. | — | Education | In-kind items and services | $8.45 | General |
| 04/28/2023 | AbbVie Inc. | — | Education | In-kind items and services | $8.45 | General |
| 04/28/2023 | AbbVie Inc. | BOTOX (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/24/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $21.94 | General |
| 03/28/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $29.57 | General |
About Dr. Prem Tripathi, MD
Dr. Prem Tripathi, MD is a Plastic Surgery Within the Head and Neck healthcare provider based in Alamo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1265875702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prem Tripathi, MD has received a total of $2,812 in payments from pharmaceutical and medical device companies, with $535.56 received in 2024. These payments were reported across 72 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($2,728).
Ad
Practice Information
- Specialty Plastic Surgery Within the Head and Neck
- Location Alamo, CA
- Active Since 04/15/2013
- Last Updated 09/22/2023
- Taxonomy Code 2082S0099X
- Entity Type Individual
- NPI Number 1265875702
Products in Payments
- NUVENT (Device) $452.04
- DAXXIFY (Drug) $427.70
- Xeomin (Biological) $218.06
- FUSION (Device) $178.48
- PROPEL (Device) $50.00
- BOTOX (Biological) $30.02
- Sophono (Device) $28.37
- BOTOX COSMETIC (Biological) $19.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.